QTL |
GWAS Catalog Study |
Disease Trait |
Study Size |
Risk Allele |
Risk Allele Frequency |
P Value |
P Value MLOG |
Peak Marker |
Reported Odds Ratio or Beta-coefficient |
Ontology Accession |
PubMed |
GWAS610594_H |
GCST90246777 |
Complement C3b levels |
10,708 European ancestry individuals |
C |
0.21 |
9E-17 |
16.046 |
rs2230199 |
0.134 |
complement C3B measurement (EFO:0020275)
|
PMID:34648354 |
GWAS676234_H |
GCST001579 |
Age-related macular degeneration (choroidal neovascularisation) |
1,775 European ancestry choroidal neovascularization cases, 4,134 European ancestry controls |
C |
0.193 |
1E-12 |
12 |
rs2230199 |
1.61 |
wet macular degeneration (EFO:0004683)
|
PMID:22705344 |
GWAS676241_H |
GCST001578 |
Age-related macular degeneration (geographic atrophy) |
819 European ancestry geographic atrophy cases, 4,134 European ancestry controls |
C |
.19 |
5E-13 |
12.302 |
rs2230199 |
1.83 |
atrophic macular degeneration (EFO:1001492)
|
PMID:22705344 |
GWAS677839_H |
GCST001884 |
Age-related macular degeneration |
6,713 European ancestry cases, 48,402 European ancestry contols, 110 Southern Indian ancestry cases, 119 Southern Indian ancestry controls, 827 Japanese ancestry cases, 3,323 Japanese ancestry controls |
C |
0.2 |
1E-41 |
41 |
rs2230199 |
1.42 |
age-related macular degeneration (EFO:0001365)
|
PMID:23455636 |
GWAS678084_H |
GCST000653 |
Age-related macular degeneration |
979 cases, 1,709 controls |
? |
NR |
2E-8 |
7.699 |
rs2230199 |
N/A |
age-related macular degeneration (EFO:0001365)
|
PMID:20385826 |
GWAS681569_H |
GCST003219 |
Advanced age-related macular degeneration |
16,144 European ancestry cases, 17,832 European ancestry controls |
? |
NR |
4E-69 |
68.398 |
rs2230199 |
1.43 |
atrophic macular degeneration (EFO:1001492) age-related macular degeneration (EFO:0001365) wet macular degeneration (EFO:0004683)
|
PMID:26691988 |
GWAS693885_H |
GCST000806 |
Age-related macular degeneration |
684 European ancestry cases, 188 European ancestry controls |
C |
NR |
1E-8 |
8 |
rs2230199 |
1.44 |
age-related macular degeneration (EFO:0001365)
|
PMID:20861866 |
GWAS698333_H |
GCST001100 |
Age-related macular degeneration |
2,594 European ancestry cases, 4,134 European ancestry controls |
C |
0.19 |
5E-29 |
28.302 |
rs2230199 |
1.53 |
age-related macular degeneration (EFO:0001365)
|
PMID:21665990 |
GWAS699973_H |
GCST000652 |
Age-related macular degeneration |
2,157 European ancestry cases, 1,150 European ancestry controls |
C |
0.163 |
1E-10 |
10 |
rs2230199 |
1.74 |
age-related macular degeneration (EFO:0001365)
|
PMID:20385819 |
GWAS745110_H |
GCST005359 |
Disease progression in age-related macular degeneration |
1,105 progressed eyes and 3,912 non-progressed eyes from 2,721 European ancestry individuals |
G |
0.24 |
1E-9 |
9 |
rs2230199 |
1.45 |
age-related macular degeneration (EFO:0001365) disease progression measurement (EFO:0008336)
|
PMID:29346644 |
GWAS849667_H |
GCST90089593 |
Serum levels of protein HLA-DRB3 |
5,351 Icelandic ancestry individuals |
C |
0.2359 |
2E-21 |
20.699 |
rs2230199 |
0.197548 |
blood protein measurement (EFO:0007937)
|
PMID:35078996 |
GWAS942868_H |
GCST90162444 |
Complement C3d fragment levels |
2,935 Qatari ancestry individuals |
C |
0.116695 |
2E-13 |
12.699 |
rs2230199 |
0.306816 |
complement C3D fragment measurement (EFO:0020277)
|
PMID:36168886 |
GWAS947460_H |
GCST90137937 |
Complement C3d fragment levels |
1,852 African American or Afro-Caribbean individuals |
? |
NR |
1E-16 |
16 |
rs2230199 |
0.42 |
complement C3D fragment measurement (EFO:0020277)
|
PMID:34814699 |
None Available |
GCST90446797 |
Age-related macular degeneration |
2,394 European ancestry cases, 2,393 European ancestry controls |
? |
NR |
3E-20 |
19.523 |
rs2230199 |
N/A |
age-related macular degeneration (EFO:0001365)
|
PMID:37934784 |
None Available |
GCST90448094 |
Age-related macular degeneration |
2,123 European ancestry cases, 2,704 European ancestry controls |
? |
NR |
4E-24 |
23.398 |
rs2230199 |
1.649 |
age-related macular degeneration (EFO:0001365)
|
PMID:37975850 |